Cd79B-Specific Car T-Cell Therapy: Overcoming Treatment Resistance In B-Cell Lymphoma

CD79b-specific CAR T-cell therapy: overcoming treatment resistance in B-cell lymphoma

VJHemOnc – Video Journal of Hematology & HemOnc

CAR T-cell Therapy Can Help Overcome Resistance to Treatment

The future of CAR T-cell therapy in B-cell malignancies

VJHemOnc – Video Journal of Hematology & HemOnc

How successful is CAR-T for B-cell lymphoma?

Update on CAR T-Cell Therapy | LRF Webinars

Lymphoma Research Foundation

CAR T-cell therapy in B-cell malignancies

VJHemOnc – Video Journal of Hematology & HemOnc

Updates on CAR T-cell therapy in B-cell malignancies

VJHemOnc – Video Journal of Hematology & HemOnc

Resisting CAR-T resistance in lymphoma: the strategies

VJHemOnc – Video Journal of Hematology & HemOnc

Efficacy of bispecific CD19/CD22 CAR T-cells in B-cell malignancies

VJHemOnc – Video Journal of Hematology & HemOnc

Optimizing the Use of CAR T-Cell Therapy in Lymphoma

CAR T-cell therapy toxicities in B-cell lymphomas

VJHemOnc – Video Journal of Hematology & HemOnc

CAR-T for lymphoma: new targets, real world data & resistance

VJHemOnc – Video Journal of Hematology & HemOnc

Understanding Resistance to CAR T Immunotherapy to Develop Better Therapies

CD5.CAR T-cell therapy in patients with T-cell lymphoma

VJHemOnc – Video Journal of Hematology & HemOnc

Lymphoma: Overview of Chimeric Antigen Receptor (CAR) T cells

Harvard Medical School Continuing Education

CAR-T cell therapies in T-cell lymphoma and leukemia

VJHemOnc – Video Journal of Hematology & HemOnc

Overcoming resistance to CAR-T therapy in CLL with ibrutinib & venetoclax

VJHemOnc – Video Journal of Hematology & HemOnc

CAR T-Cell Therapy: Treatment for Lymphomas and Leukemia

CAR T-Cell Therapy: Relapsed/Refractory ALL

ZUMA-19: maximizing safety of CAR T-cell therapy in LBCL

VJHemOnc – Video Journal of Hematology & HemOnc